Talk:Insulin lispro

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Insulin lispro.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Comments

"Engineered through recombinant DNA technology, the penultimate lysine and proline residues on the C-terminal end of the B-chain are reversed. This modification does not alter receptor binding..."

According to the scholarly journal article, Correlations of Receptor Binding and Metabolic and Mitogenic Potencies of Insulin Analogs Designed for Clinical Use, by Peter Kurtzhals, Lauge Schäffer, Anders Sørensen, Claus Kristensen, Ib Jonassen, Christoph Schmid, and Thomas Trüb, published in Diabetes June 2000 vol. 49 no. 6 pp. 999-1005, insulin lispro has different receptor binding properties than normal human insulin:

It's insulin receptor affinity is 84% (± 6%) of human insulin, and its Insulin-Like Growth Factor 1 receptor affinity is 156% (± 16%) of human insulin.

The statement "...does not alter receptor binding..." is a misleading generalization.

205.118.82.151 (talk) 22:14, 30 September 2010 (UTC)[reply]

What is the make of the clear material that the insulin is immersed in?

I understand that plastic eroding by insulin (I use Humalog Lispro) is actually caused by the stuff it's immersed and dissolved in. What is it?פשוט pashute ♫ (talk) 17:51, 4 September 2017 (UTC)[reply]